vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Wheels Up Experience Inc. (UP). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $183.8M, roughly 1.1× Wheels Up Experience Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -15.7%, a 24.0% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -10.2%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-58.3M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -3.4%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Wheels Up is a provider of "on demand" private aviation in the United States and one of the largest private aviation companies in the world. It was founded in 2013 by Kenny Dichter, using a membership/on-demand business model. Wheels Up members can book private aircraft from the company fleet and third-party operators using a mobile application.
COLL vs UP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $183.8M |
| Net Profit | $17.0M | $-28.9M |
| Gross Margin | 62.5% | 14.3% |
| Operating Margin | 29.6% | -0.9% |
| Net Margin | 8.3% | -15.7% |
| Revenue YoY | 12.9% | -10.2% |
| Net Profit YoY | 35.3% | 67.0% |
| EPS (diluted) | $0.48 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $183.8M | ||
| Q3 25 | $209.4M | $185.5M | ||
| Q2 25 | $188.0M | $189.6M | ||
| Q1 25 | $177.8M | $177.5M | ||
| Q4 24 | $181.9M | $204.8M | ||
| Q3 24 | $159.3M | $193.9M | ||
| Q2 24 | $145.3M | $196.3M | ||
| Q1 24 | $144.9M | $197.1M |
| Q4 25 | $17.0M | $-28.9M | ||
| Q3 25 | $31.5M | $-83.7M | ||
| Q2 25 | $12.0M | $-82.3M | ||
| Q1 25 | $2.4M | $-99.3M | ||
| Q4 24 | $12.5M | $-87.5M | ||
| Q3 24 | $9.3M | $-57.7M | ||
| Q2 24 | $19.6M | $-97.0M | ||
| Q1 24 | $27.7M | $-97.4M |
| Q4 25 | 62.5% | 14.3% | ||
| Q3 25 | 61.7% | 6.8% | ||
| Q2 25 | 57.7% | 8.3% | ||
| Q1 25 | 54.8% | 10.8% | ||
| Q4 24 | 54.0% | 13.9% | ||
| Q3 24 | 60.8% | 13.9% | ||
| Q2 24 | 62.5% | 2.3% | ||
| Q1 24 | 63.1% | -0.6% |
| Q4 25 | 29.6% | -0.9% | ||
| Q3 25 | 29.7% | -33.1% | ||
| Q2 25 | 18.7% | -31.4% | ||
| Q1 25 | 12.2% | -45.5% | ||
| Q4 24 | 20.9% | -26.0% | ||
| Q3 24 | 21.9% | -21.6% | ||
| Q2 24 | 32.7% | -40.3% | ||
| Q1 24 | 34.1% | -42.9% |
| Q4 25 | 8.3% | -15.7% | ||
| Q3 25 | 15.0% | -45.1% | ||
| Q2 25 | 6.4% | -43.4% | ||
| Q1 25 | 1.4% | -55.9% | ||
| Q4 24 | 6.9% | -42.7% | ||
| Q3 24 | 5.9% | -29.8% | ||
| Q2 24 | 13.5% | -49.4% | ||
| Q1 24 | 19.1% | -49.4% |
| Q4 25 | $0.48 | $-0.04 | ||
| Q3 25 | $0.84 | $-0.12 | ||
| Q2 25 | $0.34 | $-0.12 | ||
| Q1 25 | $0.07 | $-0.14 | ||
| Q4 24 | $0.36 | $-0.13 | ||
| Q3 24 | $0.27 | $-0.08 | ||
| Q2 24 | $0.52 | $-0.14 | ||
| Q1 24 | $0.71 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $133.9M |
| Total DebtLower is stronger | — | $671.3M |
| Stockholders' EquityBook value | $301.7M | $-392.1M |
| Total Assets | $1.7B | $968.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $133.9M | ||
| Q3 25 | $285.9M | $125.3M | ||
| Q2 25 | $222.2M | $107.0M | ||
| Q1 25 | $197.8M | $171.8M | ||
| Q4 24 | $162.8M | $216.4M | ||
| Q3 24 | $120.0M | $115.9M | ||
| Q2 24 | $271.6M | $141.5M | ||
| Q1 24 | $318.0M | $180.9M |
| Q4 25 | — | $671.3M | ||
| Q3 25 | — | $766.5M | ||
| Q2 25 | — | $770.5M | ||
| Q1 25 | — | $765.8M | ||
| Q4 24 | — | $761.3M | ||
| Q3 24 | — | $596.9M | ||
| Q2 24 | — | $597.4M | ||
| Q1 24 | — | $603.2M |
| Q4 25 | $301.7M | $-392.1M | ||
| Q3 25 | $274.8M | $-374.5M | ||
| Q2 25 | $232.2M | $-347.8M | ||
| Q1 25 | $234.4M | $-288.1M | ||
| Q4 24 | $228.8M | $-202.1M | ||
| Q3 24 | $234.3M | $-117.7M | ||
| Q2 24 | $216.6M | $-72.2M | ||
| Q1 24 | $222.2M | $936.0K |
| Q4 25 | $1.7B | $968.8M | ||
| Q3 25 | $1.6B | $973.0M | ||
| Q2 25 | $1.6B | $1.0B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.1B | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 644.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-18.4M |
| Free Cash FlowOCF − Capex | $122.4M | $-58.3M |
| FCF MarginFCF / Revenue | 59.6% | -31.7% |
| Capex IntensityCapex / Revenue | 0.3% | 21.7% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-259.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $-18.4M | ||
| Q3 25 | $78.4M | $-37.1M | ||
| Q2 25 | $72.4M | $-62.9M | ||
| Q1 25 | $55.4M | $-47.9M | ||
| Q4 24 | $84.6M | $37.9M | ||
| Q3 24 | $-9.0M | $-16.9M | ||
| Q2 24 | $67.4M | $-25.2M | ||
| Q1 24 | $61.9M | $-73.8M |
| Q4 25 | $122.4M | $-58.3M | ||
| Q3 25 | $78.3M | $-60.4M | ||
| Q2 25 | $72.4M | $-78.6M | ||
| Q1 25 | $54.6M | $-62.6M | ||
| Q4 24 | $84.1M | $-70.2M | ||
| Q3 24 | $-9.2M | $-21.9M | ||
| Q2 24 | $67.1M | $-30.8M | ||
| Q1 24 | $61.4M | $-77.8M |
| Q4 25 | 59.6% | -31.7% | ||
| Q3 25 | 37.4% | -32.6% | ||
| Q2 25 | 38.5% | -41.5% | ||
| Q1 25 | 30.7% | -35.3% | ||
| Q4 24 | 46.2% | -34.3% | ||
| Q3 24 | -5.8% | -11.3% | ||
| Q2 24 | 46.2% | -15.7% | ||
| Q1 24 | 42.3% | -39.5% |
| Q4 25 | 0.3% | 21.7% | ||
| Q3 25 | 0.1% | 12.5% | ||
| Q2 25 | 0.0% | 8.3% | ||
| Q1 25 | 0.4% | 8.3% | ||
| Q4 24 | 0.3% | 52.8% | ||
| Q3 24 | 0.2% | 2.6% | ||
| Q2 24 | 0.2% | 2.9% | ||
| Q1 24 | 0.4% | 2.0% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
